Genmab | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
Agios Pharmaceuticals USD 78.96M 2.72M 2025-03
Almirall EUR 329.41M 15.11M 2024-06
Amarin USD 156.94M 58.98M 2024-09
Amgen USD 8.81B 3.16B 2025-03
AstraZeneca USD 5.23B 258M 2025-03
Bayer EUR 6.19B 1.57B 2024-12
BioMarin Pharmaceutical USD 612.03M 1.19M 2025-03
Demant 1.11B 64M 2024-12
Exelixis USD 217.37M 40.97M 2025-01
Fresenius Medical Care EUR 1.07B 109M 2025-03
Galapagos EUR 108.07M 43.83M 2025-03
Genmab DKK 9.86B 3.52B 2024-12
GlaxoSmithKline GBP 4.46B 594M 2025-03
GN Store Nord DKK 787M 99M 2025-03
GRIFOLS EUR 979.78M 334.84M 2024-12
Hikma Pharmaceutical USD 0 1000K 2024-06
Insmed USD 555.03M 93.58M 2024-12
Lonza CHF 1.11B 286M 2024-12
Merck EUR 2.15B 1.01B 2024-12
Novartis USD 8.87B 4.74B 2024-12
Regeneron Pharmaceuticals USD 3.09B 14.82B 2025-03
Roche Holding CHF 6.98B 2.15B 2024-12
Sanofi 7.99B 550M 2025-03
UCB EUR 1.57B 1.14B 2024-12



Genmab Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.